SpeedWeed

AUGUST 16, 2021

and industry-leading Cannabis Business Times, Cannabis Dispensary, and Hemp Grower magazines, announces today President of Scottsdale Research Institute (SRI) Sue Sisley, MD, as the keynote speaker on Day 2 of its annual event, to take place Aug. 24-26, 2021, at Paris Las Vegas Hotel & Casino. 25 from 11 a.m. – 24-26, 2021.

Media 52

Media Clinical Trials DEA Hemp 52

Cannabis Law Report

JANUARY 14, 2020

On top of all that, even as marijuana manufacturing has boomed in the United States, all marijuana research must be done with product sourced from the sole place with a DEA license, the University of Mississippi (apparently their weed is genetically closer to hemp than anything on the modern commercial market).

Clinical Trials 69

Clinical Trials Programs Access DEA 69

Cannabis Law Report

MARCH 21, 2019

One variation of cannabis is called hemp. The industrial hemp plant happens to contain large quantities of special cannabinoids known as cannabidiol or CBD for short. On December 12, 2018 Congress passed the 2018 Farm Bill that removed hemp-derived products from the Schedule 1 list under the Controlled Substances Act.

State Laws 55

State Laws Law CBD Legalization 55

Cannabis Law Report

APRIL 1, 2019

It aims to turn the plants’ chemical compounds into 2,500 5-milliliter bottles – the size of a teaspoon – of cannabis oil and sublingual drops for clinical trials among volunteer patients as early as July. It remains to be seen whether the Drug Enforcement Authority, or DEA, will designate cannabis zones for these farmers.

Research and Development 40

Research and Development Pharmaceutical Clinical Trials DEA 40

SpeedWeed

MARCH 5, 2021

One, they have been determined by the US Food and Drug Administration to be clinically safe and effective treatments for a specific medical condition. Two, they are federally classified by DEA and HHS as Schedule II, III, IV or V substances. Rescheduling cannabis will not necessarily facilitate clinical research.

Business 52

Business Policy Clinical Trials Research and Development 52

SpeedWeed

DECEMBER 28, 2018

And then you scroll a little further down and discover that the new Farm Bill is going to legalize hemp farming in the United States for the first time in eighty years ( huzzah!). RELATED STORY. The Top 10 Cannabis Stories of 2018. Or that Big Tobacco just invested $2.4 billion dollars in the weed business ( f**k!).

Pharmaceutical 40

Pharmaceutical Research and Development Legalization CBD 40

The Cannigma

JUNE 14, 2021

All that is about to change, thanks to a change at the DEA , which cultivators and industry experts say will be monumental for cannabis research, medical marijuana patients, and potentially the broader legal status of the plant itself. “We Junk’ cannabis ‘ill-suited for clinical trials’. BRC) told The Cannigma this week.

DEA 133

DEA Research and Development Clinical Trials Pharmaceutical 133

Veriheal

AUGUST 31, 2020

However, social and economic barriers like racial stereotypes and lack of access to care centers have historically barred Hispanic community members from seeking medical cannabis and participating in clinical trials. Essay: “The Nature of Hemp and Law: Hazy Regulation”. There are restrictions on where and when hemp can be grown.

Research and Development 119

Research and Development Education Agriculture Patients 119

Canna Law Blog

JANUARY 3, 2023

Until recently, CBD resided in a legal penumbra where hemp was still scheduled on the federal Controlled Substances Act and could not be cultivated without a permit from the Drug Enforcement Administration (“DEA”). A little CBD history. The 2018 Farm Bill didn’t regulate CBD though.

CBD 97

CBD Food Clinical Trials Pets 97

Cannabis Law Report

FEBRUARY 10, 2022

Court of Appeals for the Ninth Circuit dismissed a petition for review of a Drug Enforcement Administration (DEA) response to an attorney’s letter seeking advice and guidance on how a physician could administer psilocybin to a terminally ill patient without incurring liability under the Controlled Substances Act (CSA). By Allison Campbell.

DEA 52

DEA Clinical Trials Policy Research and Development 52

Cannabis Law Report

JUNE 4, 2021

pipeline of hemp-based CBD products to Brazil, Mexico and other countries, and we’ve had tremendous demand for our products. Dr. Titus has been involved in the development and investment of several industry-leading cannabis and industrial hemp businesses during his most recent career. from the Open International University. “We

Research and Development 105

Research and Development Seed-To-Sale Cannabinoids THC 105

SpeedWeed

MARCH 25, 2021

A long-awaited clinical trial on using cannabis as a treatment for veterans with PTSD has finally been published in the PLOS One journal , but the results are far less promising than researchers and veterans had hoped. million grant from the Multidisciplinary Association of Psychedelic Studies (MAPS).

DEA 52

DEA Clinical Trials THC Pharmaceutical 52

Cannabis Law Report

JULY 12, 2019

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. 32: United States DEA.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Weedistry

MARCH 7, 2019

A team of Spanish scientists led by Manuel Guzman conducted the first clinical trial assessing the antitumoral action of THC on human beings. Guzman administered pure THC via a catheter into the tumors of nine hospitalized patients with glioblastoma, who had failed to respond to standard brain-cancer therapies.

THC 40

THC CBD Clinical Trials Research and Development 40